Abatacept 68225-0241
Product NDC
68225-0241- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- July 17, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abatacept | 250 mg/15mL |
Packaging Options(1)
154 VIAL, SINGLE-USE in 1 BOX (68225-241-00) / 15 mL in 1 VIAL, SINGLE-USE